NO20005131D0 - Nye behandlinger for nervøse forstyrrelser - Google Patents

Nye behandlinger for nervøse forstyrrelser

Info

Publication number
NO20005131D0
NO20005131D0 NO20005131A NO20005131A NO20005131D0 NO 20005131 D0 NO20005131 D0 NO 20005131D0 NO 20005131 A NO20005131 A NO 20005131A NO 20005131 A NO20005131 A NO 20005131A NO 20005131 D0 NO20005131 D0 NO 20005131D0
Authority
NO
Norway
Prior art keywords
new treatments
nervous disorders
reboxetine
noradrenaline reuptake
new
Prior art date
Application number
NO20005131A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005131L (no
Inventor
Adriana Dubini
John Michael Mccall
Duncan Paul Taylor
Philip F Von Voigtlander
Erik Ho Fong Wong
Original Assignee
Pharmacia & Upjohn Spa
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa, Upjohn Co filed Critical Pharmacia & Upjohn Spa
Publication of NO20005131L publication Critical patent/NO20005131L/no
Publication of NO20005131D0 publication Critical patent/NO20005131D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20005131A 1998-04-13 2000-10-12 Nye behandlinger for nervøse forstyrrelser NO20005131D0 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8163298P 1998-04-13 1998-04-13
IT98MI000870 IT1305322B1 (it) 1998-04-23 1998-04-23 Uso di reboxetina per il trattamento di disturbi nervosi
US8503398P 1998-05-11 1998-05-11
PCT/US1999/004288 WO1999052518A2 (en) 1998-04-13 1999-04-02 New treatments for nervous disorders

Publications (2)

Publication Number Publication Date
NO20005131L NO20005131L (no) 2000-10-12
NO20005131D0 true NO20005131D0 (no) 2000-10-12

Family

ID=11379879

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005131A NO20005131D0 (no) 1998-04-13 2000-10-12 Nye behandlinger for nervøse forstyrrelser

Country Status (25)

Country Link
US (1) US6391876B1 (ru)
EP (1) EP1071418B1 (ru)
JP (1) JP2002511408A (ru)
KR (1) KR100555279B1 (ru)
CN (1) CN1197569C (ru)
AT (1) ATE277617T1 (ru)
AU (1) AU755612B2 (ru)
BR (1) BR9909476A (ru)
CA (1) CA2320722A1 (ru)
DE (1) DE69920679T2 (ru)
DK (1) DK1071418T3 (ru)
EA (1) EA003546B1 (ru)
ES (1) ES2228035T3 (ru)
HU (1) HUP0101748A3 (ru)
IL (1) IL138887A0 (ru)
IT (1) IT1305322B1 (ru)
NO (1) NO20005131D0 (ru)
NZ (1) NZ507693A (ru)
PL (1) PL194039B1 (ru)
PT (1) PT1071418E (ru)
SI (1) SI1071418T1 (ru)
SK (1) SK14482000A3 (ru)
TR (1) TR200002970T2 (ru)
WO (1) WO1999052518A2 (ru)
ZA (1) ZA200004480B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500827B2 (en) * 1998-05-08 2002-12-31 Pharmacia & Upjohn Company Drug combinations
EP1500395B1 (en) * 1999-07-01 2006-03-08 Pharmacia & Upjohn Company LLC Reboxetine for treating fibromyalgia and other somatoform disorders
PT1632234E (pt) 1999-07-01 2007-07-09 Pharmacia & Upjohn Co Llc (s,s)-reboxetina para o tratamento da síndrome de fadiga crónica
CA2426069A1 (en) * 2000-11-15 2002-05-23 David Michelson Treatment of anxiety disorders
BR0311878A (pt) * 2002-06-17 2005-04-05 Pharmacia Italia Spa Sais farmacêuticos de reboxetina
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en) * 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
EP0919234A3 (en) 1997-10-17 1999-08-25 Eli Lilly And Company Potentiation of pharmaceuticals by moxonidine

Also Published As

Publication number Publication date
HUP0101748A2 (hu) 2001-11-28
IT1305322B1 (it) 2001-05-04
JP2002511408A (ja) 2002-04-16
TR200002970T2 (tr) 2001-01-22
DE69920679D1 (de) 2004-11-04
DK1071418T3 (da) 2005-01-03
PL194039B1 (pl) 2007-04-30
CN1293569A (zh) 2001-05-02
HUP0101748A3 (en) 2001-12-28
NO20005131L (no) 2000-10-12
KR100555279B1 (ko) 2006-03-03
DE69920679T2 (de) 2006-03-02
EA200001058A1 (ru) 2001-04-23
AU3635199A (en) 1999-11-01
CA2320722A1 (en) 1999-10-21
NZ507693A (en) 2003-08-29
US6391876B1 (en) 2002-05-21
ITMI980870A1 (it) 1999-10-23
CN1197569C (zh) 2005-04-20
EA003546B1 (ru) 2003-06-26
SI1071418T1 (en) 2005-04-30
PT1071418E (pt) 2004-12-31
SK14482000A3 (sk) 2001-08-06
WO1999052518A3 (en) 1999-12-02
BR9909476A (pt) 2000-12-19
ES2228035T3 (es) 2005-04-01
WO1999052518A2 (en) 1999-10-21
EP1071418B1 (en) 2004-09-29
EP1071418A2 (en) 2001-01-31
IL138887A0 (en) 2001-11-25
AU755612B2 (en) 2002-12-19
ATE277617T1 (de) 2004-10-15
PL346294A1 (en) 2002-01-28
KR20010042641A (ko) 2001-05-25
ZA200004480B (en) 2002-04-24

Similar Documents

Publication Publication Date Title
NO20005131D0 (no) Nye behandlinger for nervøse forstyrrelser
UA43385C2 (uk) Спосіб лікування синдрому дефіциту уваги/гіперактивності
DE602004015257D1 (de) Verwendung von dem (1s,2r)-milnacipran-enantiomer zur herstellung eines arzneimittels
IL201038A0 (en) Use of the enantiomer (1s, 2r) of milnacipran for the preparation of a medicament
ES2166110T3 (es) Agonistas no alostericos de gabaa para tratar trastornos del sueño.
MY134110A (en) Combinations of reboxetine and neuroleptic agents
ATE329588T1 (de) Verwendung von sibutramin zur behandlung von von organischen störungen verursachten zns- erkrankungen
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
DE50313386D1 (de) Mittelwalze eines Kalanders mit einer Tilgeranordnung
AR021155A1 (es) Tratamiento de desordenes neuroticos
WO2002077198A3 (en) Methods of modulating angiogenesis
PT1075264E (pt) Novas combinacoes farmacologicas de reboxetina e pindolol
MY136367A (en) Treatment of cognitive failure
BR0115301A (pt) Uso de um inibidor seletivo da recaptação de norepinefrina
PT1282414E (pt) Compostos derivados de felbamato para o tratamento da dor neuropatica
ATE481167T1 (de) Katalysator für die hydrierung von ungesättigten kohlenwasserstoffen
ECSP992873A (es) Metodo para tratar desordenes compulsivos, obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso, y autismo (caso cn0823)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application